SUBSCRIBE
SUBSCRIBE
News   Drug Development

ARCA Discovery Inc. Gets Fast-Track Status for Heart Drug

November 24, 2009 | 
1 min read
Bookmark and Share

Reuters -- ARCA biopharma Inc said U.S. health regulators granted a fast-track designation for its experimental drug, Gencaro, to treat chronic heart failure, sending its shares up as much as 81 percent.
Clinical research Phase 2
MORE ON THIS TOPIC
Podcast
As FDA Moves Away From Animal Testing, AI and Organoids Can Shine
February 17, 2026
 · 
1 min read
 · 
Jef Akst
A bottle of a vaccine on a reflective surface with the illuminated red outline of the world map in red - 3D render
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
February 16, 2026
 · 
3 min read
 · 
Annalee Armstrong
Achieve goal concept art collage. Rising arrow chart and halftone hand pointing to center of dartboard. Business goal, achieve targets, success. Trendy modern retro vector illustration
Rare diseases
‘Highly Impressive’ Data Propels BridgeBio’s Achondroplasia Drug Forward
February 12, 2026
 · 
2 min read
 · 
Tristan Manalac
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
February 12, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker